1. Home
  2. XERS vs CNNE Comparison

XERS vs CNNE Comparison

Compare XERS & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • CNNE
  • Stock Information
  • Founded
  • XERS 2005
  • CNNE 2014
  • Country
  • XERS United States
  • CNNE United States
  • Employees
  • XERS N/A
  • CNNE N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • CNNE Restaurants
  • Sector
  • XERS Health Care
  • CNNE Consumer Discretionary
  • Exchange
  • XERS Nasdaq
  • CNNE Nasdaq
  • Market Cap
  • XERS 1.3B
  • CNNE 1.1B
  • IPO Year
  • XERS 2018
  • CNNE N/A
  • Fundamental
  • Price
  • XERS $7.36
  • CNNE $19.20
  • Analyst Decision
  • XERS Strong Buy
  • CNNE Buy
  • Analyst Count
  • XERS 7
  • CNNE 3
  • Target Price
  • XERS $8.00
  • CNNE $23.33
  • AVG Volume (30 Days)
  • XERS 1.9M
  • CNNE 662.8K
  • Earning Date
  • XERS 11-07-2025
  • CNNE 11-11-2025
  • Dividend Yield
  • XERS N/A
  • CNNE 3.13%
  • EPS Growth
  • XERS N/A
  • CNNE N/A
  • EPS
  • XERS N/A
  • CNNE N/A
  • Revenue
  • XERS $246,025,000.00
  • CNNE $437,200,000.00
  • Revenue This Year
  • XERS $43.89
  • CNNE N/A
  • Revenue Next Year
  • XERS $20.40
  • CNNE N/A
  • P/E Ratio
  • XERS N/A
  • CNNE N/A
  • Revenue Growth
  • XERS 35.62
  • CNNE N/A
  • 52 Week Low
  • XERS $2.69
  • CNNE $15.92
  • 52 Week High
  • XERS $8.03
  • CNNE $22.36
  • Technical
  • Relative Strength Index (RSI)
  • XERS 51.35
  • CNNE 52.45
  • Support Level
  • XERS $7.56
  • CNNE $18.43
  • Resistance Level
  • XERS $7.89
  • CNNE $19.44
  • Average True Range (ATR)
  • XERS 0.24
  • CNNE 0.38
  • MACD
  • XERS -0.14
  • CNNE 0.16
  • Stochastic Oscillator
  • XERS 2.90
  • CNNE 78.67

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About CNNE Cannae Holdings Inc.

Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.

Share on Social Networks: